LXS.DE: a 2028 sale it can force
Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.
Lanxess can force Advent to buy at least half its Envalior stake in April 2028, potentially raising about €745 million to reduce net debt.
@darkstarsats 6/x $NN) thus, as you agreed, mid-band is more valuable if it has low-band to support it. Thus, the FCC is incentivized to support $NN, which we know they are doing b/c they issued a draft NPRM, which is admittedly stuck in OIRA review. For now.
@darkstarsats 5/x $NN) This is what customers actually care about. You can get around this by building more towers and hanging more radios and using midband for control, but that is less efficient and more expensive.
@darkstarsats 4/x $NN) Low band carries the control signal that a tells a phone what to do. When to transmit data. When to switch towers etc. B/c low band travels farther than mid band, low band is needed to stitch together the network and make sure calls are not dropped / garbled etc.
@darkstarsats 3/x $NN) so while you are calling $NN's 15 MHz of low a "small slice" in reality it is not much smaller than what $T bought, and it could be multiples of what they have AVAILABLE
@darkstarsats 2/x $NN) This why $T bought 20 mhz of low band from $ECHO. $VZ and $TMUS have more subs than $T and about the same amount of low band. Logically, $VZ and $TMUS must also be dealing with low band congestion.
@darkstarsats 1/x $NN) you note that carriers "control" ~50 mhz of low-band each. respectfully, "control" is clearly not the relevant variable. how much they have AVAILALBLE is what matters. $T commented that they were capacity constrained on low band.
Shorting low P/Es sometimes works: $SSTK and $GETY https://t.co/aRCDW2nrC2
King William as my son likes to refer to him out with his first public position. Don’t sleep on him. $LIFE https://t.co/598FwOWcDh
LendingTree derives roughly two-thirds of revenue from insurance and trades near 4 times expected adjusted earnings despite record revenue,…
Occidental Petroleum’s debt should fall further after Q3 oil prices averaged $85 per barrel WTI and $91 Brent.
Elutia’s antibiotic-eluting surgical matrices target breast-surgery infections, with Minot Light valuing $100 million in sales at a…
Hess Midstream, Iovance Biotherapeutics, Netlist and nine other lesser-covered stocks make this week’s Undercovered Dozen.
SiriusXM trades at 6.5 times free cash flow, a 15% yield, with high short interest and catalysts that could drive a short squeeze.
Gloo's $3.25 follow-on, going-concern warning and $28.0 million first-half cash burn frame the short case against its acquisition-driven…
Tower Properties, $TPRP, went dark after a 2006 squeeze-out cut holders below 300, leaving a Kemper-controlled apartment and office…
Bumble agreed to a $1.3 billion take-private deal, while Netflix cut about 1,000 jobs and Meta discussed its Muse superintelligence models.
Dorchester Minerals' 9.5% normalized yield and debt-free royalty model are offset by limited upside at $29.71, as extraordinary…
SKIN · long SkinHealth Systems owns a dominant professional skincare consumables franchise but trades at roughly $115 million market cap and $255…
Oruka Therapeutics’ ORKA-001 posted PASI 90 and PASI 100 psoriasis responses at week 28; $1.1 billion of cash funds development through a…
Tuya’s $976 million cash pile equals 94% of its $1.04 billion market cap as its smart-home platform returned to 16% revenue growth in Q2…
Fannie Mae and Freddie Mac could leave conservatorship through a 2026 restructuring and IPO, monetizing the government’s equity stake while…
PesoRama will reach 54 JOi Dollar Plus stores by November after raising C$28.4 million, funding more than 50 additional Mexican store…
Modine, soon Modexus Solutions, has a $4 billion hyperscaler cooling contract but must ramp factory output and restore margins as data…
Dream Finders Homes’ controlling owner borrowed against DFH stock before the homebuilder agreed to finance an acquisition with costly…
Park Aerospace’s 11% Q2’27 sell-off overlooks sole-source PAC-3 rocket-motor materials and A320neo engine composites, with missile capacity…
UniQure's Huntington's gene therapy faces an FDA accelerated-approval decision around November 1 after three-year data met both agency…
Transocean’s Valaris merger clears regulators, creating a 68-rig offshore driller controlling four in 10 global drillships.
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.